文献速递安宁疗护

在实用性临床试验中保护重症患者人群

Protecting seriously ill populations during pragmatic clinical trials.
PubMed 文献 · J Am Geriatr Soc · 2023-03-22

实用性临床试验(PCT)强调真实世界效果,但最小化数据收集负担可能遗漏患者报告结局,导致重症等脆弱人群的安全性信息缺口。本文以利物浦路径和俄勒冈州POLST实施为例,主张采用基于风险的方法在PCT中增加数据收集以捕捉潜在安全性和患者体验结局。

要点

  • PCT优先利用现有数据源减少收集负担,但可能遗漏患者报告结局,影响脆弱人群安全性评估。
  • 现有PCT准备度排名系统对增加数据收集负担的研究给予较低排名,导致患者体验指标被广泛省略。
  • 本文主张基于风险的方法,在PCT中增加数据收集以捕捉潜在安全性和患者体验结局。

核心结论

  • 本文主张对实用性临床试验采用基于风险的方法增加额外数据收集,以捕捉潜在安全性和患者体验结局。

研究设计与样本

  • 本文为观点性文章,以利物浦路径和俄勒冈州POLST实施等真实世界干预为例进行论证。

主要发现

  • PCT优先使用现有数据源以最小化数据收集负担,但缺乏患者报告结局可能导致重症等脆弱人群的安全性信息缺口。
  • 现有PCT准备度排名系统对施加额外数据收集负担的研究给予较低排名,导致医疗利用和成本指标广泛使用而患者体验指标被省略。

临床怎么用

  • 在PCT中可考虑基于风险的方法增加数据收集,以捕捉潜在安全性和患者体验结局。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pragmatic clinical trials (PCTs) emphasize real-world effectiveness methodology to address the limitations of results from explanatory randomized clinical trials (RCTs), which often fail to translate to real-world medical practice. An inherent tension in the conduct of PCTs is that the research must impose a minimal burden on patients and health care institutions. PCTs prioritize outcome measures from existing data sources to minimize data collection burden; however, a lack of patient-reported outcomes may result in gaps in safety for vulnerable populations, such as those with serious illnesses. One proposed standard for judging the readiness of a study for a pragmatic trial is a ranking system that assigns PCTs a lower rank if they impose additional data collection burdens. However, this results in the wide use of measures of health care utilization and costs while patient experience measures, which could capture adverse unintended consequences, are omitted. In this article, we make the case for a risk-based approach to imposing additional data collection in PCTs to capture potential safety and patient experience outcomes, using examples from "real life" implemented interventions to improve end-of-life care through the Liverpool Pathway and through the implementation of Physician Orders for Life Sustaining Treatment (POLST) in Oregon.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Teno JM, Hanson LC, Lima JC, et al. Protecting seriously ill populations during pragmatic clinical trials. J Am Geriatr Soc. 2023. PMID: 36949574. doi:10.1111/jgs.18333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。